Skip to main content
Erschienen in: Heart and Vessels 4/2022

22.09.2021 | Original Article

Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons

verfasst von: Naoki Yoshioka, Takahiro Tokuda, Akio Koyama, Takehiro Yamada, Ryusuke Nishikawa, Kiyotaka Shimamura, Kensuke Takagi, Yasuhiro Morita, Akihito Tanaka, Hideki Ishii, Itsuro Morishima, Toyoaki Murohara, on the ASIGARU PAD investigators

Erschienen in: Heart and Vessels | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Both polymer-coated paclitaxel-eluting stents (PC-PESs) and drug-coated balloons (DCBs) are used in conjunction with endovascular therapy (EVT) for the treatment of peripheral artery disease (PAD). We aimed to identify the risk factors for the loss of patency following the use of PC-PES and DCB in a real clinical setting. We assessed the multi-center registry data of 151 lesions from 151 patients who underwent EVT for symptomatic PAD in the superficial femoral and proximal popliteal arteries using PC-PES or DCB. One-year primary patency (PP) and clinically driven target lesion revascularization (CD-TLR) were evaluated using Kaplan–Meier analysis. The predictive risk factors for 1-year outcomes were analyzed using the random survival forest method. PC-PES and DCB were used in 65 (43.0%) and 86 (57.0%) cases, respectively. There were no significant differences in 1-year PP or freedom from CD-TLR between PC-PES and DCB. PP occurred in 85.4% and 80.2% of cases in the PC-PES and DCB groups, respectively (log-rank p = 0.65), while freedom from CD-TLR was noted in 92.7% and 94.1% of cases in the PC-PES and DCB groups, respectively (log-rank p = 0.73). In order of importance, a Clinical Frailty Scale score ≥ 6, female sex, lower proximal vessel diameter, lower body mass index, and younger and older age were identified as predictive risk factors of restenosis in the PC-PES group. Peripheral artery calcification scoring system grade of ≥ 2, post-dissection pattern ≥ D, lower proximal and distal vessel diameter, and lesion length ≥ 100 mm were identified as predictive risk factors of restenosis, in order of importance, in the DCB group. Both PC-PES and DCB were associated with favorable clinical outcomes within 1 year in patients with femoropopliteal artery disease. Furthermore, several factors that could predict restenosis within 1 year following the use of each device were detected.
Literatur
1.
Zurück zum Zitat Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Muller-Hulsbeck S (2018) A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet 392(10157):1541–1551PubMed Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Muller-Hulsbeck S (2018) A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet 392(10157):1541–1551PubMed
2.
Zurück zum Zitat Müller-Hülsbeck S, Keirse K, Zeller T, Schroë H, Diaz-Cartelle J (2017) Long-term results from the MAJESTIC Trial of the eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3-year follow-up. Cardiovasc Intervent Radiol 40(12):1832–1838PubMed Müller-Hülsbeck S, Keirse K, Zeller T, Schroë H, Diaz-Cartelle J (2017) Long-term results from the MAJESTIC Trial of the eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3-year follow-up. Cardiovasc Intervent Radiol 40(12):1832–1838PubMed
3.
Zurück zum Zitat Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G (2019) Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv 12(6):e007702PubMedPubMedCentral Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G (2019) Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv 12(6):e007702PubMedPubMedCentral
4.
Zurück zum Zitat Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Ulrich M, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Scheinert D (2020) COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J 41(27):2541–2552PubMedPubMedCentral Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Ulrich M, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Scheinert D (2020) COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J 41(27):2541–2552PubMedPubMedCentral
5.
Zurück zum Zitat Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, Brucks S, Lottes AE, Scheinert D, Steiner S (2019) Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease. J Am Coll Cardiol 73(6):667–679PubMed Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, Brucks S, Lottes AE, Scheinert D, Steiner S (2019) Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease. J Am Coll Cardiol 73(6):667–679PubMed
6.
Zurück zum Zitat Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E (2014) Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther 21(3):359–368PubMed Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E (2014) Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther 21(3):359–368PubMed
7.
Zurück zum Zitat Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, d’Adamo A, Salvatori FM (2014) Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 37(4):898–907PubMed Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, d’Adamo A, Salvatori FM (2014) Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 37(4):898–907PubMed
8.
Zurück zum Zitat Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T (2018) Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT Global Study. JACC Cardiovasc Interv 11(10):945–953PubMed Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T (2018) Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT Global Study. JACC Cardiovasc Interv 11(10):945–953PubMed
9.
Zurück zum Zitat Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW (2015) Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65(9):931–941PubMedPubMedCentral Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW (2015) Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65(9):931–941PubMedPubMedCentral
10.
Zurück zum Zitat Gillett MJ (2009) (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 32(7), 1327–1334. Clin Biochem Rev 30(4):197–200PubMedPubMedCentral Gillett MJ (2009) (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 32(7), 1327–1334. Clin Biochem Rev 30(4):197–200PubMedPubMedCentral
11.
Zurück zum Zitat Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K (2013) Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb 20(6):517–523PubMed Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K (2013) Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb 20(6):517–523PubMed
12.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMed
13.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992PubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992PubMed
15.
Zurück zum Zitat Gregorevic KJ, Hubbard RE, Lim WK, Katz B (2016) The clinical frailty scale predicts functional decline and mortality when used by junior medical staff: a prospective cohort study. BMC Geriatr 16:117PubMedPubMedCentral Gregorevic KJ, Hubbard RE, Lim WK, Katz B (2016) The clinical frailty scale predicts functional decline and mortality when used by junior medical staff: a prospective cohort study. BMC Geriatr 16:117PubMedPubMedCentral
16.
Zurück zum Zitat Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495PubMedPubMedCentral Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495PubMedPubMedCentral
17.
Zurück zum Zitat Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367–375PubMed Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367–375PubMed
18.
Zurück zum Zitat Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212-220PubMed Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212-220PubMed
19.
Zurück zum Zitat Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Takahara M, Uematsu M (2016) Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther 23(5):731–737PubMed Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Takahara M, Uematsu M (2016) Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther 23(5):731–737PubMed
20.
Zurück zum Zitat Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS (2008) Random survival forests. Ann Appl Stat 2:841–860 Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS (2008) Random survival forests. Ann Appl Stat 2:841–860
21.
Zurück zum Zitat Breiman L (2001) Random forests. Mach Learn 45:5–32 Breiman L (2001) Random forests. Mach Learn 45:5–32
22.
Zurück zum Zitat Friedman J (2001) Greedy function approximation: a gradient boosting machine. Ann Stat 29:1189–1232 Friedman J (2001) Greedy function approximation: a gradient boosting machine. Ann Stat 29:1189–1232
23.
Zurück zum Zitat Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T, Collet J-P, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I and Group ESD (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816PubMed Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T, Collet J-P, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I and Group ESD (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816PubMed
24.
Zurück zum Zitat Bisdas T, Beropoulis E, Argyriou A, Torsello G, Stavroulakis K (2018) 1-Year all-comers analysis of the eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty. JACC Cardiovasc Interv 11(10):957–966PubMed Bisdas T, Beropoulis E, Argyriou A, Torsello G, Stavroulakis K (2018) 1-Year all-comers analysis of the eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty. JACC Cardiovasc Interv 11(10):957–966PubMed
25.
Zurück zum Zitat Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, Nobuyoshi M (2011) Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg 54(4):1058–1066PubMed Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, Nobuyoshi M (2011) Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg 54(4):1058–1066PubMed
26.
Zurück zum Zitat Tsujimura T, Takahara M, Iida O, Hiramori S, Hayakawa N, Karashima E, Miura T, Teramura M, Ichihashi K, Kojima T, Aihara H, Yamaoka T, Fujihara M, Tosaka A, Doijiri T, Mano T, Soga Y (2019) One-year clinical outcomes following implantation of innova (TM) self-expanding nitinol stents in patients with peripheral artery diseases presenting femoropopliteal artery lesions. J Atheroscler Thromb 26(10):847–855PubMedPubMedCentral Tsujimura T, Takahara M, Iida O, Hiramori S, Hayakawa N, Karashima E, Miura T, Teramura M, Ichihashi K, Kojima T, Aihara H, Yamaoka T, Fujihara M, Tosaka A, Doijiri T, Mano T, Soga Y (2019) One-year clinical outcomes following implantation of innova (TM) self-expanding nitinol stents in patients with peripheral artery diseases presenting femoropopliteal artery lesions. J Atheroscler Thromb 26(10):847–855PubMedPubMedCentral
27.
Zurück zum Zitat Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M (2015) 1-Year results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis. JACC Cardiovasc Interv 8(8):1105–1112PubMed Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M (2015) 1-Year results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis. JACC Cardiovasc Interv 8(8):1105–1112PubMed
28.
Zurück zum Zitat Stavroulakis K, Donas KP, Torsello G, Osada N, Schönefeld E (2015) Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease. J Endovasc Ther 22(1):31–37PubMed Stavroulakis K, Donas KP, Torsello G, Osada N, Schönefeld E (2015) Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease. J Endovasc Ther 22(1):31–37PubMed
29.
Zurück zum Zitat Kurata N, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Mano T (2020) Factors INFLUENCING IN-STENT OCCLUSION AFTER FEMOROPOPLITEAL ARTERY STENT PLACEMENT WITH INTRAVASCULAR ULTRASOUND EVALUATION. J Vasc Interv Radiol 31(2):213–220PubMed Kurata N, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Mano T (2020) Factors INFLUENCING IN-STENT OCCLUSION AFTER FEMOROPOPLITEAL ARTERY STENT PLACEMENT WITH INTRAVASCULAR ULTRASOUND EVALUATION. J Vasc Interv Radiol 31(2):213–220PubMed
30.
Zurück zum Zitat Krishnan P, Tarricone A, Purushottam B, Chen S, Kapur V, Gujja K, Kini A, Sharma S (2020) Gender differences in the outcomes of drug-coated balloon treatment in symptomatic femoropopliteal arterial disease. Vasc Endovascular Surg 54(4):348–354PubMed Krishnan P, Tarricone A, Purushottam B, Chen S, Kapur V, Gujja K, Kini A, Sharma S (2020) Gender differences in the outcomes of drug-coated balloon treatment in symptomatic femoropopliteal arterial disease. Vasc Endovascular Surg 54(4):348–354PubMed
31.
Zurück zum Zitat Jones D, Song X, Mitnitski A, Rockwood K (2005) Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin Exp Res 17(6):465–471PubMed Jones D, Song X, Mitnitski A, Rockwood K (2005) Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin Exp Res 17(6):465–471PubMed
32.
Zurück zum Zitat Mitnitski A, Song X, Skoog I, Broe GA, Cox JL, Grunfeld E, Rockwood K (2005) Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 53(12):2184–2189PubMed Mitnitski A, Song X, Skoog I, Broe GA, Cox JL, Grunfeld E, Rockwood K (2005) Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 53(12):2184–2189PubMed
33.
Zurück zum Zitat Graham MM, Galbraith PD, O’Neill D, Rolfson DB, Dando C, Norris CM (2013) Frailty and outcome in elderly patients with acute coronary syndrome. Can J Cardiol 29(12):1610–1615PubMed Graham MM, Galbraith PD, O’Neill D, Rolfson DB, Dando C, Norris CM (2013) Frailty and outcome in elderly patients with acute coronary syndrome. Can J Cardiol 29(12):1610–1615PubMed
34.
Zurück zum Zitat Yoshioka N, Takagi K, Morishima I, Morita Y, Uemura Y, Inoue Y, Umemoto N, Shibata N, Negishi Y, Yoshida R, Tanaka A, Ishii H, Murohara T (2019) Influence of preadmission frailty on short- and mid-term prognoses in octogenarians with ST-elevation myocardial infarction. Circ J 84(1):109–118PubMed Yoshioka N, Takagi K, Morishima I, Morita Y, Uemura Y, Inoue Y, Umemoto N, Shibata N, Negishi Y, Yoshida R, Tanaka A, Ishii H, Murohara T (2019) Influence of preadmission frailty on short- and mid-term prognoses in octogenarians with ST-elevation myocardial infarction. Circ J 84(1):109–118PubMed
35.
Zurück zum Zitat Gonzalez L, Kassem M, Owora AH, Seligson MT, Richards CY, Monita MM, Cardounell SZ, Brangman SA, Gahtan V (2019) Frailty and biomarkers of frailty predict outcome in veterans after open and endovascular revascularization. J Surg Res 243:539–552PubMed Gonzalez L, Kassem M, Owora AH, Seligson MT, Richards CY, Monita MM, Cardounell SZ, Brangman SA, Gahtan V (2019) Frailty and biomarkers of frailty predict outcome in veterans after open and endovascular revascularization. J Surg Res 243:539–552PubMed
36.
Zurück zum Zitat Takeji Y, Yamaji K, Tomoi Y, Okazaki J, Tanaka K, Nagae A, Jinnouchi H, Hiramori S, Soga Y, Ando K (2018) Impact of frailty on clinical outcomes in patients with critical limb ischemia. Circ Cardiovasc Interv 11(7):e006778PubMed Takeji Y, Yamaji K, Tomoi Y, Okazaki J, Tanaka K, Nagae A, Jinnouchi H, Hiramori S, Soga Y, Ando K (2018) Impact of frailty on clinical outcomes in patients with critical limb ischemia. Circ Cardiovasc Interv 11(7):e006778PubMed
37.
Zurück zum Zitat Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS (2006) Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol 110(2):153–159PubMed Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS (2006) Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol 110(2):153–159PubMed
38.
Zurück zum Zitat Knudtson MD, Klein BE, Klein R, Shankar A (2005) Associations with weight loss and subsequent mortality risk. Ann Epidemiol 15(7):483–491PubMed Knudtson MD, Klein BE, Klein R, Shankar A (2005) Associations with weight loss and subsequent mortality risk. Ann Epidemiol 15(7):483–491PubMed
39.
Zurück zum Zitat Ludhwani D, Wu J (2019) Obesity paradox in peripheral arterial disease: results of a propensity match analysis from the national inpatient sample. Cureus 11(5):e4704PubMedPubMedCentral Ludhwani D, Wu J (2019) Obesity paradox in peripheral arterial disease: results of a propensity match analysis from the national inpatient sample. Cureus 11(5):e4704PubMedPubMedCentral
40.
Zurück zum Zitat Keller K, Hobohm L, Geyer M, Münzel T, Lavie CJ, Ostad MA, Espinola-Klein C (2019) Obesity paradox in peripheral artery disease. Clin Nutr 38(5):2269–2276PubMed Keller K, Hobohm L, Geyer M, Münzel T, Lavie CJ, Ostad MA, Espinola-Klein C (2019) Obesity paradox in peripheral artery disease. Clin Nutr 38(5):2269–2276PubMed
41.
Zurück zum Zitat Soga Y, Iida O, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H (2020) Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty. J Endovasc Ther 27(6):946–955PubMed Soga Y, Iida O, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H (2020) Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty. J Endovasc Ther 27(6):946–955PubMed
42.
Zurück zum Zitat Schmidt A, Piorkowski M, Gorner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D (2016) Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC Cardiovasc Interv 9(7):715–724PubMed Schmidt A, Piorkowski M, Gorner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D (2016) Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC Cardiovasc Interv 9(7):715–724PubMed
43.
Zurück zum Zitat Tepe G, Zeller T, Schnorr B, Claussen CD, Beschorner U, Brechtel K, Scheller B, Speck U (2013) High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther 20(6):792–800PubMed Tepe G, Zeller T, Schnorr B, Claussen CD, Beschorner U, Brechtel K, Scheller B, Speck U (2013) High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther 20(6):792–800PubMed
45.
Zurück zum Zitat Miki K, Fujii K, Tanaka T, Yanaka K, Yoshihara N, Nishimura M, Sumiyoshi A, Horimatsu T, Imanaka T, Fukunaga M, Akahori H, Masuyama T, Ishihara M (2020) Impact of IVUS-derived vessel size on midterm outcomes after stent implantation in femoropopliteal lesions. J Endovasc Ther 27(1):77–85PubMed Miki K, Fujii K, Tanaka T, Yanaka K, Yoshihara N, Nishimura M, Sumiyoshi A, Horimatsu T, Imanaka T, Fukunaga M, Akahori H, Masuyama T, Ishihara M (2020) Impact of IVUS-derived vessel size on midterm outcomes after stent implantation in femoropopliteal lesions. J Endovasc Ther 27(1):77–85PubMed
46.
Zurück zum Zitat Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T (2020) Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 27(5):693–705PubMed Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T (2020) Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 27(5):693–705PubMed
Metadaten
Titel
Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons
verfasst von
Naoki Yoshioka
Takahiro Tokuda
Akio Koyama
Takehiro Yamada
Ryusuke Nishikawa
Kiyotaka Shimamura
Kensuke Takagi
Yasuhiro Morita
Akihito Tanaka
Hideki Ishii
Itsuro Morishima
Toyoaki Murohara
on the ASIGARU PAD investigators
Publikationsdatum
22.09.2021
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2022
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-021-01941-9

Weitere Artikel der Ausgabe 4/2022

Heart and Vessels 4/2022 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.